Suchergebnisse - "Cohn, Danny M"

PubPharm (3)

1

A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema

enthalten in: Allergy | 2024

von Petersen, R. | Bordone, L. | Riedl, M. | +13

2

An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema : a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial

enthalten in: Lancet (London, England) | 2023

von Aygören-Pürsün, E. | Zanichelli, A. | Cohn, D. | +23

CommentIn: Lancet. 2023 Feb 11;401(10375):413-415. - PMID 36774145

3

Inhibition of Prekallikrein for Hereditary Angioedema

enthalten in: The New England journal of medicine | 2022

von Fijen, L. | Riedl, M. | Bordone, L. | +14

CommentIn: N Engl J Med. 2022 Mar 17;386(11):1083-1085. - PMID 35294818

1
[1]